Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure
In Japan, the dose of the new recombinant antithrombin III concentrate (rAT-gamma) is titrated according to patient body weight (BW), while conventional plasma-derived antithrombin concentrates (AT) are administered as a fixed dose. Therefore, it is anticipated that rAT-gamma could produce better tr...
Main Authors: | Hiromitsu Kuroda MD, Yoshiki Masuda MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029620981630 |
Similar Items
-
Correction of Antithrombin III Deficiency in Disseminated Intravascular Coagulation
by: Ye. L. Neporada, et al.
Published: (2008-10-01) -
Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation
by: Hiroyuki Nagafuchi MD, et al.
Published: (2019-03-01) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01) -
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
by: Hayakawa M
Published: (2017-12-01) -
An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome
by: Shigeatsu Endo, et al.
Published: (2018-11-01)